2h ago
India weighs 0.3%–0.5% merchant fee on select high-value UPI payments
India is considering reintroducing a merchant discount rate (MDR) on certain high-value Unified Payments Interface (UPI) transactions, potentially charging eligible large merchants 0.3%–0.5%. The proposal would apply to payments above 2,000 rupees ($20.97) for merchants with annual turnover exceeding 15 million rupees, shifting UPI away from its current zero-fee model. Transactions above 2,000 rupees represent 4% of merchant payment volumes but about 67% of transaction value, according to a Jefferies report.
2h ago
2h ago
Energizer posts fiscal Q3 2026 net sales of $734.1 million, trims full-year adjusted EPS and EBITDA outlook to range low end
Energizer Holdings reported fiscal third-quarter results for the period ended June 30, 2026, with net sales of $734.1 million, up 1.2% year over year, and organic net sales growth of 2.7%. Gross margin was 38.2%, or 39.2% on an adjusted basis, while earnings per share were $0.58 and adjusted EPS was $0.75. The company also updated its fiscal 2026 guidance by moving adjusted EPS and adjusted EBITDA expectations to the low end of the ranges it previously provided, according to Energizer Holdings, Inc.
2h ago
2h ago
Smith+Nephew cuts 2026 revenue growth outlook to around 4% as U.S. knee implant demand weakens
Smith+Nephew lowered its 2026 full-year revenue growth forecast to around 4% from about 6%, citing notably weak demand for knee implants in the U.S. Second-quarter revenue rose 1.6%, missing analysts’ expectations of 3.7%, according to Reuters. Orthopaedics revenue fell 1%, with U.S. knee implants down 7.2% and U.S. hip implants down 1.5%. The shares slid as much as 7.9% intraday.
2h ago
2h ago
SOPHiA GENETICS reports Q2 2026 revenue of $23.3 million, raises 2026 outlook to $94 million–$96 million
SOPHiA GENETICS reported second-quarter 2026 revenue of $23.3 million, up 27% year over year, with a reported gross margin of 64.6%. Net loss was $22.4 million, flat year over year, while adjusted EBITDA loss narrowed 27% to $8.8 million. The company raised its 2026 revenue guidance to $94 million–$96 million, and said U.S. analysis volume rose 60% year over year, according to the company.
2h ago
2h ago
Morepen posts record Q1 FY27 revenue of Rs. 575.31 Cr and PAT of Rs. 56.35 Cr as EBITDA jumps 207%
Morepen Laboratories reported record quarterly revenue of Rs. 575.31 Cr for Q1 FY27 ended June 30, 2026, up 34% YoY, and PAT of Rs. 56.35 Cr, up 394% YoY. EBITDA rose 207% YoY to Rs. 87.72 Cr, lifting the EBITDA margin to 15.25% from 6.65% in Q1 FY26. The company said its Rs. 825 Cr CDMO mandate has entered the full-scale commercialization phase, with Rs. 58 Cr of commercial CDMO dispatches completed in Q1 FY27.
2h ago
2h ago
United Parks & Resorts posts Q2 2026 results as attendance slips to 6.1 million and net income falls 21.0%
United Parks & Resorts Inc. reported second-quarter 2026 attendance of 6.1 million guests, down 2.9% from the same period in 2025. Total revenue declined 1.4% to $483.3 million, while net income fell 21.0% to $63.3 million and Adjusted EBITDA decreased 5.2% to $195.5 million. The company said total revenue per capita rose 1.5% to $79.82 as inpark per capita spending increased 5.1% to a record $39.51, while admission per capita fell 1.8% to $40.31.
2h ago